A New York appellate court ruled on June 3, 2026, in the case of Chaya v. Maimonides Medical Center, impacting the standards for medical malpractice claims in neonatal care. The court's decision affects how hospitals and medical professionals approach treatment for premature infants, particularly regarding informed consent and adherence to accepted medical practices.
The case arose when Yaffa Chaya, the parent of an infant born prematurely at 24 weeks and 4 days gestation, filed a lawsuit against Maimonides Medical Center. Chaya claimed the medical staff at the hospital failed to provide adequate care for her infant, leading to significant health issues. The dispute centered on whether the medical team met the accepted standards of care and whether they properly informed Chaya about the risks associated with the treatment provided.
Initially, Chaya's lawsuit included multiple claims of medical malpractice and lack of informed consent. However, during the legal proceedings, she narrowed her allegations to four main points. These included claims that the hospital staff did not intubate the infant or administer surfactant promptly after birth, failed to conduct a proper differential diagnosis for the infant's oxygen desaturation, did not provide a second dose of surfactant in a timely manner, and delayed transfusing packed red blood cells to address anemia and hypoxia.
The case reached the Appellate Division of the Supreme Court of the State of New York after the Supreme Court, Kings County, denied Maimonides Medical Center's motion for summary judgment. This motion sought to dismiss the complaint entirely, arguing that the hospital did not deviate from accepted medical practices. The hospital's appeal followed the lower court's decision, which allowed the case to proceed.
The court ruled on several aspects of the case. It found that the medical center had established that it did not deviate from accepted medical standards regarding the claims of failure to intubate and administer surfactant promptly. The court stated, "The defendant demonstrated, prima facie, that it did not depart from the accepted standard of care with respect to the plaintiff's allegations that it failed to intubate the infant and administer surfactant promptly following delivery." This ruling was based on the testimony of a board-certified physician who affirmed that the medical team acted appropriately under the circumstances.
However, the court also highlighted that the hospital did not adequately prove that its failure to administer a second dose of surfactant and the delay in transfusing packed red blood cells did not constitute a departure from the standard of care. The ruling noted, "The defendant failed to establish, prima facie, that its failure to administer a second dose of surfactant to the infant within 8 to 12 hours after the initial dose was not a departure from the standard of care, or that such a departure was not a proximate cause of the infant's injuries."
Additionally, the court ruled in favor of the hospital regarding the lack of informed consent claim, stating that Chaya did not raise a triable issue of fact in opposition to the hospital's motion. The court concluded, "The Supreme Court should have granted that branch of the defendant's motion which was for summary judgment dismissing the cause of action to recover damages for lack of informed consent."
This ruling has significant implications for medical malpractice cases, especially those involving neonatal care. It clarifies the responsibilities of medical professionals in providing timely treatment and the importance of informed consent. Hospitals and medical staff must now be more vigilant in documenting their practices and ensuring they meet established medical standards to avoid liability.
The outcome of this case may influence future medical malpractice claims, particularly those involving premature infants and similar medical scenarios. It underscores the necessity for healthcare providers to maintain clear communication with patients and their families regarding treatment options and potential risks.
Looking ahead, it remains unclear whether the plaintiff will seek further appeal in this matter. The court's ruling, as it stands, sets a precedent for how courts may handle similar medical malpractice cases in the future. Details regarding any related cases or potential appeals were not available in the court filing.